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Abstract
Recombinant adenoviruses are efficient gene transfer vehicles that could be used for treatment of acute diseases. However, the time
required for adenoviruses to produce physiologically relevant levels of transgene in vivo is unknown. To address this question rat lungs were
infected with an E1a/E3a adenovirus that contains an hCMV-driven human 2-adrenergic receptor (2AR) cDNA. Human 2AR
message and protein expression were noted 2–4 h postinfection without evidence of pseudotransduction. 2AR function (cAMP production)
was increased at 6 h postinfection. To determine when 2AR gene transfer affects downstream catecholamine-sensitive pathways, we
measured lung Na,K-ATPase expression and alveolar fluid clearance (AFC). 2AR gene transfer increased Na,K-ATPase number by 80%
at 6 h, and AFC by 20% at 8 h postinfection. These data indicate that recombinant adenoviruses can produce physiologically significant
levels of transgene within hours of infection and that they may be suitable for gene therapies for acute, rapidly progressive diseases.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Gene transfer offers the potential to alter the pathophys-
iology of acute, rapidly progressive conditions such as
stroke, asthma, myocardial infarction, lung injury, and in-
fectious diseases (Factor, 2001). Gene therapy for these
conditions will require a highly efficient gene transfer vec-
tor that can produce transgene within hours of administra-
tion. Although nonviral methodologies are capable of very
early transgene expression (Manthorpe et al., 1993), viral
vehicles remain the vectors of choice when highly efficient
transduction is required. Numerous viral vectors are avail-
able; many (retrovirus, lentiviruses, adenoassociated vi-
ruses) require days or weeks to achieve physiologically
relevant levels of transgene expression. Adenoviruses are
capable of highly efficient gene transfer; however, most
studies using these vectors evaluated transgene expression
and function beginning 1–3 days postinfection. There are no
data regarding when recombinant adenoviruses first produce
physiologically significant levels of transgene in vivo.
With respect to the lung, several acute processes, includ-
ing pulmonary edema, acute respiratory distress syndrome,
and pneumonia, have pathophysiologic processes that might
be interrupted by modulation of gene expression. The ac-
cessibility of the lung and the relative tropism of adenovi-
ruses for respiratory epithelial cells make these acute pul-
monary processes especially attractive for adenoviral-
mediated gene therapies. Several groups have approached
these processes in experimental systems using recombinant
adenoviruses and have been able to favorably affect funda-
mental pathophysiologic processes. For example, adenovi-
ral-mediated overexpression of Na,K-ATPase subunit genes
in the alveolar epithelium enhances pulmonary edema clear-
ance and protects from acute lung injury due to hyperoxia
(Factor et al., 2000), acute elevations of left atrial pressure
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(Azzam et al., 2002), and high-tidal volume ventilation
(Adir et al., 2002). Other groups have used gene transfer to
overexpress interferon-, TNF, and IL-12 in mouse air-
ways to enhance host responses to pulmonary infection and
accelerate clearance of bacteria (Greenberger et al., 1996;
Lei et al., 1997; Standiford et al., 1999). Other less acute
processes such as asthma and chronic obstructive lung dis-
ease also represent attractive targets for lung gene transfer
(Mathieu et al., 1999). Each of these studies highlight the
potential of gene transfer for an acute disease.
In the current study we tested when a recombinant ade-
novirus first produces detectable and physiologically signif-
icant levels of a relevant transgene in vivo. To do so, we
transduced the alveolar epithelium of normal rats with a
first-generation, replication-incompetent adenovirus that ex-
presses a human 2-adrenergic receptor (2AR) cDNA
(ad2AR) and then measured transgene expression and
function in the distal lung at serial time points following
infection. This gene was selected based on recent studies
showing that its overexpression produces physiologically
important effects in the alveolar epithelium of rats by in-
creasing alveolar epithelial active Na transport (Dumasius
et al., 2001). The presence of this human transgene can be
detected in rat tissues and its function and downstream
physiologic effects can be measured using established tools.
Thus the 2AR is a good candidate gene to determine the
time points at which recombinant adenoviruses first produce
transgene.
Results
Pseudotransduction
Reverse-transcriptase-PCR (RT-PCR) and Western anal-
yses were used to determine if CsCl-purified preparations of
ad2AR contain detectable quantities of human 2AR
mRNA or protein which might account for detection of
transgene shortly after infection (pseudotransduction). No
2AR mRNA was noted by RT-PCR following Proteinase
K and DNAse treatment of a quantity of ad2AR that
corresponds to the dose of virus given to rats in this study (4
 109 PFU, 1  1011 viral particles). Similarly, no pro-
tein was detected in the same quantity of ad2AR by West-
ern analysis (10–50 g protein/lane).
Onset of message expression in the distal lung of rats
Adult male Sprague–Dawley rats were infected with 4
109 PFU of ad2AR 0–24 h prior to study (Factor et al.,
1998a). RT-PCR using DNAse-treated total RNA harvested
from the peripheral left lung revealed human 2AR mRNA
at 2 h postinfection (Fig. 1, top blot). Message levels of rat
2AR did not change significantly during the time frame of
this study (Fig. 1, bottom blot). Levels of the human 2AR
mRNA rose from 41% of human 2AR at 2 h to 102% at
24 h (Fig. 1, graph).
Appearance of human 2AR protein in the distal lung
Western analysis of whole-cell membrane fractions col-
lected from the distal lung 0–24 h after infection with
ad2AR shows the presence of a human 2AR at 4 h
postinfection using 10 g protein/lane (Fig. 2, top blot).
Levels of the human transgene declined slightly during the
time course shown in Fig. 2.
Timing of changes in 2AR function (Fig. 3)
Procaterol-induced cAMP production by cell membranes
(2AR function) from the peripheral lung was measured to
determine when adenoviral-mediated 2AR gene transfer
increases membrane-bound 2AR function. Receptor func-
tion in membranes from ad2AR-infected rats was greater
than adNull-infected controls at 6 h postinfection (ad2AR;
1.62  0.18 vs adNull; 0.80  0.13 pmol cAMP/mg pro-
tein, P  0.02).
Fig. 1. Postinfection timing of appearance of human 2AR mRNA in distal
rat lung. Reverse transcriptase PCR of total RNA from the peripheral left
lung for human (top) and rat (bottom) 2AR mRNA and corresponding
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) at the postinfection
time points shown. PCR products shown for each time point in the top and
bottom panels are from the same rats. The graph shows relative expression
of normalized human 2AR mRNA to the same time point normalized rat
2AR mRNA. PCR products were quantified based on intensity of
ethidium bromide staining and normalized to GAPDH mRNA.
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Timing of physiologic effects of transgene function
To test when 2AR gene transfer affects lung active Na
transport, peripheral lung membranes enriched for the ba-
solateral cell membrane domain (where the Na,K-ATPase is
located) were produced and used for measurement of Na,K-
ATPase activity under conditions that allow it to function
maximally (Vmax). These conditions produce an index of the
number of functional, membrane-bound Na,K-ATPases in a
known quantity of protein. We have previously shown that
the Na,K-ATPase is a key element needed for active trans-
port in alveolar epithelial cells in vitro (Ridge et al., 1997)
and rat lungs in vivo (Azzam et al., 2002; Factor et al.,
1998a). Ouabain-sensitive liberation of inorganic phosphate
from ATP (Na,K-ATPase activity) was 80% greater in
ad2AR than in adNull-infected lungs at 6 h postinfection
(ad2AR; 0.90  0.0.4 vs adNull; 0.50  0.19 nmol Pi/mg
protein/h, P  0.01) (Fig. 4A). Alveolar fluid clearance
(AFC), an index of active vectorial Na transport by the
alveolar epithelium, was measured by determining how
much fluid can be removed from the alveolar airspace of
isolated lungs over 1 h. AFC at 6 h postinfection was
increased in both adNull- and ad2AR-infected groups due
to administration of the surfactant-based vehicle. At 8 h
postinfection, AFC in ad2AR-infected lungs was 23%
greater than in adNull lungs (ad2AR; 0.62  0.10 adNull;
0.48  0.10 ml/h, P  0.027) (Fig. 4B).
Discussion
The current study was initiated to identify the postinfec-
tion time point at which transgene expression and function
can be identified following adenoviral-mediated gene trans-
Fig. 2. Postinfection timing of appearance of human 2AR protein in distal
rat lung. Western analyses of whole-cell membrane protein (10 g protein/
lane) isolated from the peripheral right lung of rats infected with ad2AR
at the postinfection time points shown. Human 2AR protein is shown in
the top panel and rat 2AR protein is shown in the bottom panel. Syn-
chronously prepared Western blots for -actin are shown below each blot
to facilitate comparison among groups. Data shown for each time point are
from the same rat.
Fig. 3. Transgene function in rat lungs. 2AR function (procaterol-induced
cAMP production) in membranes isolated from the lungs of rats infected
with ad2AR 0–12 h following infection. Data are mean  standard
deviation of triplicate measurements from each rat. n  3 rats/group/time
point; *P  0.05 ad2AR vs same time point adNull.
Fig. 4. (A) Na,K-ATPase function (ouabain-sensitive liberation of 32Pi
from ATP under conditions of Vmax) in cell membranes isolated from the
peripheral right lung of rats infected with ad2AR or adNull at the postin-
stillation time points indicated. *P  0.02 vs surfactant controls (surf),
adNull, and 1, 2, and 4 h post-ad2AR infection. n  3 rats/group/time
point. (B) Alveolar fluid clearance in untreated/uninfected controls and rats
infected with ad2AR (n  7) or adNull (n  5) 6 or 8 h postinfection.
Clearance was measured using a fluid-filled, perfused, isolated lung prep-
aration. Data are mean standard deviation. *P 0.04 8 h ad2AR vs 8 h
adNull and untreated/uninfected controls.
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fer in vivo and to identify how long it takes for transgene
expression to upregulate a physiologically important alve-
olar epithelial function. These studies were intended to test
if recombinant adenoviruses are suitable for use when
prompt transgene expression is required.
In this study we used a surfactant-based delivery system
to transduce the alveolar epithelium of normal rats 0–24 h
before assaying for the presence of human 2AR mRNA
and protein in the distal lung (i.e., alveolus). This method
affects vector delivery to all segments of the rat lung and
leads to transgene expression that is confined to the alveolar
epithelium (Factor et al., 1999). In the current study this
method resulted in detection of human 2AR mRNA (by
RT-PCR) within 2 h after instillation of adenovirus (Fig. 1,
top). Transgene message levels at this early time point were
41% of endogenous levels and rose to 102% at 24 h. Human
2AR protein (by Western analyses) was detected in the
peripheral lung of rats at 4 h postinfection (Fig. 2, top).
Slight reductions in levels of rat 2AR protein were noted
over the time course of this study. The use of polyclonal
anti-2AR antibodies precluded quantitative comparison of
human and rat 2AR protein levels; however, it is apparent
from Fig. 2 that levels of the transgenic protein probably
exceed endogenous at 24 h postinfection. Importantly, sig-
nificant increases in 2AR function were noted at 6 h
postinfection.
The noted effects on membrane-bound receptor function
at 6 h are promising; however, our interest is in the use of
gene transfer to treat acute illnesses such as pulmonary
edema. Accordingly we probed when 2AR gene transfer
affects an alveolar epithelial function that correlates with
outcome from acute lung injury: active alveolar fluid clear-
ance (Matthay and Wiener-Kronish, 1990; Ware and Mat-
thay, 2001). These detailed studies revealed significant in-
creases in the number of functional Na,K-ATPases in
basolateral membranes from the peripheral lung at 6 h
postinfection (Fig. 4, graph A). The magnitude of increase
in Na,K-ATPase activity (80%) parallels changes in mem-
brane-bound 2AR function (100%) at the same time point.
These findings cause us to reason that the requisite machin-
ery needed to increase alveolar active transport (i.e., Na,K-
ATPase) are sensitive to cAMP and can be promptly acti-
vated or recruited to the cell membrane.
Adenoviral-mediated overexpression of transport pro-
teins in the alveolar epithelium improves alveolar active
Na transport (Factor et al., 1998a) and protects the lung
from injury (Azzam et al., 2002; Factor et al., 2000; Stern et
al., 2000). Transfer of a 2AR cDNA to the alveolar epi-
thelium of rats improves sensitivity to endogenous cat-
echolamines and increases AFC by 100% (at 7 days postin-
fection) by upregulating synthesis and function of both the
epithelial Na channel and the Na,K-ATPase in the distal
lung (Dumasius et al., 2001). These changes occur without
exogenous catecholamine supplementation. Thus, AFC is
an index of the downstream effects of -adrenergic recep-
tors in the alveolar epithelium. Based on this paradigm
additional studies were conducted by measuring AFC in
lungs isolated from rats 6 and 8 h postadenovirus adminis-
tration. Alveolar fluid clearance in ad2AR-infected lungs
was 20% greater than adNull-infected controls 8 h after
vector instillation (Fig. 4B). While our findings are prom-
ising, it is important to highlight that the instillation of our
surfactant-based vehicle into the lung increases AFC for up
to 6 h (Fig. 4B). Thus, AFC, as compared to measurement
of membrane-bound 2AR function, may be somewhat in-
sensitive to the appearance of transgene function in the
alveolus.
There are data available regarding the timing of adeno-
virus processing following receptor-mediated internaliza-
tion of adenovirus into endosomes. Matthews and col-
leagues have shown that adenoviral proteins associated with
the viral core (protein V) can be identified at the nuclear
membrane 30–60 min following infection and in the nu-
cleus within 2 h (Matthews and Russell, 1998). A report
from Binger noted the presence of early gene expression
(E1a, E3, and E4) at 4 h postinfection in HeLa cells infected
with low multiplicities of infection of wild-type adenovirus
type 2 (Binger and Flint, 1984). These data roughly corre-
spond with our findings showing that adenoviruses can
rapidly produce transgene in the lung.
We are not aware of any prior adenoviral-mediated gene
transfer study showing physiologically significant effects of
transgene expression prior to 24 h postinfection in vivo. A
prior study probed the timing of transgene expression using
a Semliki forest virus to transduce vascular smooth muscle
cells and cardiac myocytes (Roks et al., 1997). This in vitro
project noted transgene function (-galactosidase activity)
1 h postinfection, which is the earliest report of transgene
expression using a viral vector. However, this study did not
exclude the possibility of pseudotransduction. Retroviruses
(Liu et al., 1996) and adeno-associated virus (Alexander et
al., 1997) have been shown to affect transgene expression as
early as 1–3 days postinfection via pseudotransduction at-
tributed to carryover of transgene mRNA and/or protein in
crude viral lysates. In the current study we found (via
RT-PCR and Western analysis) no evidence of pseudotrans-
duction nor are we aware of other reports of cesium chloride
purified adenoviruses causing pseudotransduction.
It has been reported that synthetic surfactant spreads to
the distal lung within 30 s of endotracheal instillation in
ventilated piglets (Davis et al., 1992). Although surfactant
can impair liposomal-mediated gene transfer to lung epithe-
lial cells (Duncan et al., 1997), there are no data to suggest
that surfactant delays adenoviral entry to the cell. Thus, we
believe that our surfactant vehicle and the use of an efficient
viral promoter (CMV) facilitated the early onset of trans-
gene expression noted in this study. It is likely that adeno-
viruses are similarly efficient in other organ systems, less
certain is whether other proteins are capable of similarly
prompt physiologic effects. Thus our results must be inter-
preted in the context of the gene that we evaluated and the
“transducibility” of the lung.
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These findings represent the first systematic investigation
of the timing of onset of transgene expression and function
following adenoviral-mediated gene transfer in vivo. These
experiments establish a time line of early transgene activa-
tion, expression, and function that is associated with up-
regulation of a downstream physiologic effect (alveolar
active Na transport and fluid clearance) that can protect
from lung injury. These studies complement a recent report
from this group showing that adenoviruses efficiently trans-
duce the alveolar epithelium of severely injured, edematous
rat lungs (Factor et al., 2002). Our findings demonstrate that
recombinant adenoviruses are capable of prompt transgene
expression in rat lung and suggest that adenoviral-mediated
gene transfer might be suitable for use in acute, rapidly
progressive conditions such as acute lung injury and pul-
monary edema.
Methods and materials
Adenovirus propagation and purification
Replication-incompetent E1a/E3 human type 5 ad-
enoviruses containing either a human 2-adrenergic recep-
tor cDNA under the control of a human CMV promoter-
enhancer element (ad2AR, courtesy of Drs. R. Lefkowitz
and W. Koch, Duke University) or no cDNA (adNull) were
propagated, purified, and titered in human embryonic kid-
ney cells (HEK 293) as previously described (Factor et al.,
1998a, b). All viruses used in this study were from single
preparations and were free of signs of replication-competent
adenovirus to a maximum dilution of 109.
Study groups
The use of animals for this study was approved by the
Evanston Northwestern Healthcare Institutional Animal
Care and Use Committee. A total of 68 specific pathogen-
free adult male Sprague–Dawley rats (Harlan Laboratories,
Indianapolis, IN) were used. Lungs from rats infected with
ad2AR were harvested 0, 1, 2, 4, 8, 12, or 24 h following
vector instillation for measurement of transgene expression
and function and Na,K-ATPase activity (n  3–4 rats/time
point). For studies of alveolar fluid clearance, five to seven
animals/group/time point were compared to five untreated/
uninfected controls.
Adenovirus delivery to rat lungs
Adenovirus was delivered to rats using a previously
described method that produces widespread gene transfer to
alveolar type 1 and type 2 cells of normal and injured rat
lungs (Factor et al., 1998a, 2002). Briefly, rats were lightly
anesthetized and intubated with a 14-gauge plastic catheter
(Angiocath, Becton–Dickinson, Sandy, UT). While breath-
ing spontaneously, a mixture of adenovirus (4  109 PFU)
in a 50% surfactant (Survanta, Abbott Laboratories, Colum-
bus, OH)/50% Tris-buffered saline vehicle was adminis-
tered in four aliquots of 0.2 ml via the endotracheal tube.
Rats were rotated 90° between instillations given at 5-min
intervals. To facilitate distal dispersion of adenovirus, ex-
halation was forced by circumferential compression of the
thorax, vehicle was then instilled (followed by 0.5 ml of air)
and compression was relinquished. Rats were extubated
following recovery from anesthesia. Zero time-point ani-
mals were sacrificed immediately following vector delivery.
Cell membrane isolation
Whole-cell membrane proteins were produced from tis-
sue collected from the distal 2–3 mm of right rat lungs
following serial bronchoalveolar lavage (PBS 7 ml 5) and
perfusion of the pulmonary artery (PBS  20 ml) as pre-
viously described (Dumasius et al., 2001; Factor et al.,
1998a, 2000). Cell-membrane fractions enriched for the
basolateral cell membrane domain were produced from dis-
tal lung tissue as described previously (Azzam et al., 2002;
Dumasius et al., 2001; Hammond et al., 1994).
Reverse transcriptase PCR
Total RNA from the peripheral left lung tissue was
isolated using RNA-zol B (Tel-Test, Inc., Friendswood,
TX). RNA was treated with DNAse I (50 units for 20 min
at 37°C, Sigma, St. Louis, MO), twice extracted with phe-
nol-chloroform, precipitated, and resuspended in 20 l of
RNAse-free water prior to first-strand cDNA synthesis us-
ing oligo-(dT)12–16. PCR was performed using 2 l of the
reaction mixture at an annealing temperature of 58°C, and
30 cycles of amplification. Primer sequences for human
2AR were as follows: upstream 5ACTTCTGGTGC-
GAGTT and downstream 3GTAGCCATTCCCATAGG,
which produce a 750-bp product; for rat 2AR: upstream
5CGACTTCTTGCTGGCACCCAATGGAG and down-
stream 5TTGGCCCGGATGACGTGGACAATATTG,
which produce an 879-bp product. Primers for glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) were from BD
Biosciences. Clontech (Palo Alto, CA). PCR products were
separated by agarose gel electrophoresis and quantified
based on the intensity of ethidium bromide staining (Strat-
agene Eagle Eye II). 2AR message expression at each
postinfection time point was normalized to a separately
produced GAPDH PCR product using total RNA from the
same rat. Comparison of transgenic and endogenous 2AR
mRNA expression was performed by dividing normalized
human 2AR message expression by normalized rat 2AR
expression and multiplying by 1.16 to adjust for differences
in number of base pairs between the human and rat PCR
products.
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2AR function (Dumasius et al., 2001)
Receptor function was quantified by measuring pro-
caterol-induced cyclic-adenosine monophosphate (cAMP)
production by whole-cell membrane fractions produced
from the peripheral right lung of rats. Membranes (10 g/
reaction) were exposed to procaterol (108 M) with IBMX
(103 M), Na2ATP (2 mM), and GTP (0.2 mM) for 30 min.
Cyclic-AMP was quantified using a radioimmunoassay
(Perkin–Elmer, Inc., Boston, MA). Triplicate measurements
from three to four rats/group are presented as mean pmol
cAMP/mg protein.
Western blot analysis
Ten micrograms of membrane protein from the periph-
eral right lung was separated by 10% SDS–PAGE and
transferred to nitrocellulose as previously described (Duma-
sius et al., 2001; Thome et al., 2001). Polyclonal rabbit
anti-rat and anti-human 2AR and anti--actin antibodies
were used as primary antibodies (all from Santa Cruz Sci-
entific, Santa Cruz, CA). A chemiluminescent system
(ECL, Amersham Corp., Arlington Heights, IL) was used
for immunodetection.
Evaluation for pseudotransduction
An amount of 4  109 PFU (1011 viral particles) of
ad2AR was treated with RNAse- and DNAse-free Protein-
ase K (200 u at 37°C for 15 min, Sigma) followed by
inactivation at 65°C for 20 min, prior to treatment with
DNAse I and rtPCR as described above. Western analysis
was performed by suspending 4  109 PFU of ad2AR in
an SDS containing homogenization/loading buffer (Duma-
sius et al., 2001) prior to separation of 10, 20, and 50 g
protein/lane on a 10% PAGE and immunodetection as de-
scribed above.
Na,K-ATPase function (Pi liberation from ATP) in the
distal lung
Twenty micrograms of basolateral cell membrane pro-
tein isolated from the peripheral lung (distal 2–3 mm) was
resuspended in 100 l of a high [Na]/low [K] reaction
buffer (50 mM Tris–HCl pH 7.4, 50 mM NaCl, 5 mM KCl,
10 mM Mg2Cl, 1 mM EGTA, 10 mM Na2ATP), with
[32P]ATP (3.3 Ci/ml) as previously described (Azzam et
al., 2002; Dumasius et al., 2001). These conditions maxi-
mize Na,K-ATPase activity (Vmax) and produce an index of
functional, membrane-bound receptor number. Triplicate
samples were placed at 20°C for 15 min prior to incuba-
tion for 15 min at 37°C. The reaction was terminated by
addition of 5% TCA/10% charcoal and cooling to 4°C. The
charcoal phase containing unhydrolyzed nucleotide was
separated by centrifugation (12,000 g for 5 min) and the
liberated 32P quantified. Na,K-ATPase activity was calcu-
lated as the difference between the test samples (total/
nonspecific ATPase activity) and samples assayed in reac-
tion buffer with 2.5 mM ouabain but devoid of Na and K
(non-Na,K-ATPase ATPase activity). Results are expressed
as mean nmol of Pi***/mg of protein/h of triplicate mea-
surements from three rats/group. Na,K-ATPase activity was
measured in lungs infected with ad2AR 1–24 h postinfec-
tion. These membranes were compared to membranes from
lungs treated with surfactant vehicle or adNull 24 h prior to
collection.
Measurement of alveolar fluid clearance (Factor et al.,
1998a, 1999; Lecuona et al., 1999; Rutschman et al.,
1993)
An extensively described isolated, fluid-filled, perfused
lung preparation was used to measure the rate of fluid
removal from the alveolar airspace. Briefly, a known con-
centration of Evans blue tagged albumin was instilled into
the airspace. Fluid samples from the airspace were obtained
10 and 70 min after instillation. Changes in alveolar Evan’s
blue concentration during the 60-min experimental period
were used to calculate AFC rates (ml/h). AFC was measured
6 and 8 h following infection with 4  109 PFU of adNull
or ad2AR and was compared to uninfected controls.
Data analysis
All values are reported as means  standard deviation.
Statistical comparison among groups was performed using
one-way ANOVA (Graphpad Prism, Graphpad Software,
San Diego, CA). Statistical significance was defined as P 
0.05.
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